CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology
CRFR1-antagonism has the potential to improve and may be beneficial for stress-induced AD pathogenesis in the early phases of AD.
Authors
- Robert A. Rissman (ORCID: https://orcid.org/0000-0001-9245-8278)
- Floyd Sarsoza
- Maya Ellisman
Institutions
- University of California San Diego (US)
- VA San Diego Healthcare System (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.092978
- Primary Topic
- Stress Responses and Cortisol
- Type
- article
- Field-Weighted Citation Impact
- 0.00